- Home
- IMMP vs NBH Comparison
IMMP vs NBH Comparison
Compare IMMP & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NBH
- Stock Information
- Founded
- IMMP 1987
- NBH 2002
- Country
- IMMP Australia
- NBH United States
- Employees
- IMMP N/A
- NBH N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- IMMP Health Care
- NBH Finance
- Exchange
- IMMP Nasdaq
- NBH Nasdaq
- Market Cap
- IMMP 304.0M
- NBH 317.5M
- IPO Year
- IMMP N/A
- NBH N/A
- Fundamental
- Price
- IMMP $1.78
- NBH $10.40
- Analyst Decision
- IMMP Buy
- NBH
- Analyst Count
- IMMP 2
- NBH 0
- Target Price
- IMMP $8.50
- NBH N/A
- AVG Volume (30 Days)
- IMMP 82.5K
- NBH 85.9K
- Earning Date
- IMMP 03-25-2025
- NBH 01-01-0001
- Dividend Yield
- IMMP N/A
- NBH 4.34%
- EPS Growth
- IMMP N/A
- NBH N/A
- EPS
- IMMP N/A
- NBH 0.12
- Revenue
- IMMP $3,019,249.00
- NBH N/A
- Revenue This Year
- IMMP N/A
- NBH N/A
- Revenue Next Year
- IMMP $20.28
- NBH N/A
- P/E Ratio
- IMMP N/A
- NBH $87.04
- Revenue Growth
- IMMP 24.11
- NBH N/A
- 52 Week Low
- IMMP $1.65
- NBH $8.75
- 52 Week High
- IMMP $3.34
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- IMMP 41.69
- NBH 36.09
- Support Level
- IMMP $1.65
- NBH $10.62
- Resistance Level
- IMMP $1.88
- NBH $10.50
- Average True Range (ATR)
- IMMP 0.10
- NBH 0.08
- MACD
- IMMP -0.01
- NBH -0.04
- Stochastic Oscillator
- IMMP 41.94
- NBH 4.55
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.